Salvage Stereotactic Body Radiotherapy of the Prostate Bed for Biochemical Recurrence After Radical Prostatectomy.

This is a a randomized phase II/III trial comparing salvage SBRT with standard of care (SOC) regimens for patients with a persistent detectable PSA or biochemical progression during follow-up after radical prostatectomy.

Trial Details

NCT ID
NCT06523634
Phase
NA
Sponsor
Jules Bordet Institute
Status
RECRUITING
Cancer Type
Prostate Cancer
Interventions
  • Stereotactic body radiotherapy (SBRT)
  • SOC RT
Locations (sample)
  • Aalst, Belgium|50.93604,4.0355
  • Antwerp, Belgium|51.22047,4.40026
  • Bruges, Belgium|51.20892,3.22424
  • Brussels, Belgium|50.85045,4.34878
  • Genk, Belgium|50.965,5.50082

Key Eligibility Criteria

  • Localized adenocarcinoma (cN0M0) of the prostate treated primarily with radical prostatectomy with definitive intent.
  • Either persistent PSA after prostatectomy (PSA ≥ 0.1 ng/mL at least 6 weeks after prostatectomy), or biochemical progression (two consecutive risin…
  • WHO PS 0-1
  • Age ≥18 years

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Prostate Cancer Trials on Trialify →